FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and aims at treating ischemic heart disease. Accepted α-tocopherol 200 mg 3 times a day per os, emoxipin 1% – 4.0 ml once a day intramuscularly, delagil in dose of 250 mg 2 times a day per os. In addition, nicotinic acid 1% – 4.0 ml is prescribed intramuscularly once a day and Essentiale 10.0 ml once a day intravenously. Therapy is carried out daily for 10 days.
EFFECT: invention increases antianginal efficacy of therapy of coronary insufficiency, increase patient’s physical activity tolerance, promotes stabilization of blood pressure and normalization of lipid metabolism.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARATION OF PATIENTS FOR CORONAROGRAPHY | 1998 |
|
RU2153871C2 |
| METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE | 2010 |
|
RU2428978C1 |
| METHOD OF CARDIOVASCULAR DISEASE TREATMENT AND PREVENTION WITH USING COWSLIP PRIMROSE HERB EXTRACT | 2008 |
|
RU2353378C1 |
| METHOD TO CORRECT LIPID PEROXIDE OXIDATION IN PATIENTS SUFFERING ISCHEMIC CARDIAC DISEASE | 1999 |
|
RU2178704C2 |
| THERAPEUTIC APPROACH TO PATIENTS SUFFERING ISCHEMIA OF LOWER EXTREMITIES AND MULTIVESSEL DISEASE OF CORONARY BED | 2014 |
|
RU2553429C1 |
| METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC DISEASE TREATMENT | 1995 |
|
RU2122732C1 |
| PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH NONSTABLE STENOCARDIA AND ACUTE MYOCARDIAL INFARCTION | 2000 |
|
RU2168993C1 |
| METHOD OF CEREBRAL ISCHEMIC INSULT TREATMENT | 1996 |
|
RU2145895C1 |
| WAY OF CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2007 |
|
RU2359686C2 |
